Midodrine Medical Valley (Midodrine Hydrochloride)

Midodrine is a selective alpha‑1 adrenergic receptor agonist. By stimulating these receptors on peripheral blood vessels, it causes vasoconstriction, which increases systemic vascular resistance and elevates arterial pressure, counteracting the fall in blood pressure that occurs when a person stands up.

The dose of Midodrine Medical Valley is determined by the prescribing clinician based on the individual’s condition, response, and tolerability. The prescriber will set the appropriate strength, frequency, and duration according to current medical guidelines.

Safety data for midodrine in pregnancy and lactation are limited. It should only be used if the potential benefit justifies any potential risk to the fetus or infant, and the decision must be made by a qualified healthcare professional.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Midodrine is a direct alpha‑1 agonist, whereas other options such as fludrocortisone increase blood volume or non‑pharmacologic measures focus on lifestyle changes. Midodrine typically provides a rapid pressor effect, but its use requires monitoring for supine hypertension, a consideration less prominent with volume‑expanding agents.

Midodrine Medical Valley should be stored at ambient temperature, preferably below 25 °C. Keep the product in its original packaging, protect it from moisture and direct sunlight, and ensure the container is tightly closed to maintain stability.

The medication is taken orally, usually with a full glass of water. It is commonly prescribed to be taken during the day, avoiding doses close to bedtime to reduce the risk of supine hypertension.

The most serious risks include severe or sustained hypertension, especially when lying down, which can lead to cardiovascular complications. Patients should be educated to monitor blood pressure regularly and report any signs of chest pain, severe headache, or visual disturbances promptly.

Midodrine is contraindicated in patients with known hypersensitivity to the drug, severe organic cardiac disease, acute renal failure, or uncontrolled hypertension. It should also be avoided in individuals who cannot safely monitor supine blood pressure.